Database | Recombinant Antibodies And Mimetics Database

What can we help you find?

You are searching for:

Category A

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category B

Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation

Category C

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category D

Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category E

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category F

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with animal-derived biomaterials used in production or final formulation

Category G

Original source/host: Unknown
Discovery method: Unknown
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Uncategorised Antibodies

Uncategorised Antibodies have Antibody/Binder Origins set in such a way as to prevent them from being assigned to a valid Antibody Category.

Click here to view all Antibody Category descriptions and to search directly by Antibody Category

Category A
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category B
- Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
- Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
- Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
Search
Category C
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category D
- Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category E
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category F
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
Search
Category G
- Original source/host: Unknown
- Discovery method: Unknown
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search

6841-6850 of 8849 results

Catalogue Number:

AMM10622V

Category:

MYD88 Mouse Monoclonal Antibody [Clone ID: LBI1B8]

Target:	MYD88
Species Reactivity:	Human, Rat, Other
Applications:	Flow Cytometry, Immunofluorescence, Immunohistochemistry, Western Blot
Type:	Primary Recombinant
Host Species:	Mouse
Animal-Derived Biomaterials Used:	BSA, KLH, FCS, Other
Sequence Available	No
Original Discovery Methods	Animal-derived from single B cell, Animal-derived from hybridomas excluding ascites
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

AMM10621V

Category:

MYD88 Mouse Monoclonal Antibody [Clone ID: LBI2B2]

Target:	MYD88
Species Reactivity:	Human
Applications:	Flow Cytometry, Immunofluorescence, Immunohistochemistry, Western Blot
Type:	Primary Recombinant
Host Species:	Mouse
Animal-Derived Biomaterials Used:	BSA, KLH, FCS, Other
Sequence Available	No
Original Discovery Methods	Animal-derived from single B cell, Animal-derived from hybridomas excluding ascites
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation

Catalogue Number:

orb1726833

Category:

MYH7B Rabbit mAb Antibody

Target:	MYH7B Antibody detects endogenous levels of total MYH7B
Species Reactivity:	Human, Mouse, Rat
Application:	Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	IgG
Host Species:	Rabbit
Formulation:	Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

orb1743584

Category:

MYL9 Antibody

Target:	MYL9
Target Alias Names:	Myosin regulatory light polypeptide 9 (20 kDa myosin light chain) (LC20) (MLC-2C) (Myosin RLC) (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9) (Myosin regulatory light chain MRLC1), MYL9, MLC2 MRLC1 MYRL2
Species Reactivity:	Human
Application:	ELISA
Type:	Primary Recombinant
Isotype/Mimetic:	Human IgG2
Host Species:	Human
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

orb1174163

Category:

MYLK Antibody

Target:	MYLK
Target Alias Names:	Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], MYLK, MLCK MLCK1 MYLK1
Species Reactivity:	Human
Applications:	ELISA, Flow Cytometry, Western Blot
Type:	Primary Recombinant
Isotype/Mimetic:	Rabbit IgG
Host Species:	Rabbit
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

orb1743726

Category:

MYO7A Antibody

Target:	MYO7A
Target Alias Names:	Unconventional myosin-VIIa, MYO7A, USH1B
Species Reactivity:	Human
Applications:	ELISA, Flow Cytometry
Type:	Primary Recombinant
Isotype/Mimetic:	Rabbit IgG
Host Species:	Rabbit
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

orb689013

Category:

N Cadherin antibody

Target:	CDH2
Target Alias Names:	Cadherin-2 (CDw325) (Neural cadherin) (N-cadherin) (CD antigen CD325), CDH2, CDHN NCAD
Species Reactivity:	Human
Application:	ELISA
Type:	Primary Recombinant
Isotype/Mimetic:	Rabbit IgG
Host Species:	Rabbit
Formulation:	Liquid
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1227

Category:

Nacolomab Biosimilar – Anti-MUC1 sialylated CA242 mAb – Research Grade

Target:	MUC1 sialylated CA242
Target Alias Name:	Nacolomab/r-c242Fab-SEA/MUC1 sialylated CA242/anti-MUC1 sialylated CA242
Species Reactivity:	Human
Type:	Primary Recombinant
Isotype/Mimetic:	Fab-G1-kappa
Host Species:	Human
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1689

Category:

Nadecnemab Biosimilar – Anti-GFRA3 mAb – Research Grade

Target:	GFRA3
Target Alias Name:	Nadecnemab/IMMUNOGLOBULIN G4 (232-PROLINE)/ ANTI-(HUMAN GLIAL CELL-DERIVED NEUROTROPHIC FACTOR RECEPTOR .ALPHA.3) (HUMAN MONOCLONAL REGN5069 .GAMMA.4-CHAIN)/ DISULFIDE WITH HUMAN MONOCLONAL REGN5069 .KAPPA.-CHAIN/ DIMER/ REGN-5069/GFRA3/anti-GFRA3
Species Reactivity:	Human
Type:	Primary Recombinant
Isotype/Mimetic:	IgG4/Kappa
Host Species:	Human
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1867

Category:

Nadunolimab Biosimilar – Anti-IL1RAP mAb – Research Grade

Target:	IL1RAP
Target Alias Name:	Nadunolimab//IL1RAP/anti-IL1RAP
Species Reactivity:	Human
Type:	Primary Recombinant
Isotype/Mimetic:	IgG1 Kappa
Host Species:	Human
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Viewing 6841-6850 of 8849 results

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.